Literature DB >> 11490231

The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen.

P Emiliozzi1, S Longhi, P Scarpone, A Pansadoro, F DePaula, V Pansadoro.   

Abstract

PURPOSE: Prostate cancer detection on standard sextant biopsy is considered inadequate. Various biopsy protocols have been introduced to improve cancer diagnosis. We report our experience with transperineal 12-core prostate biopsy.
MATERIALS AND METHODS: In a prospective study 650 patients underwent prostate specific antigen (PSA) measurement during a 15-month period, of whom 141 with PSA greater than 4 ng./ml. also underwent transperineal 12-core prostate biopsy using the fan technique. Median PSA was 8 ng./ml. (range 4.1 to 5,000).
RESULTS: Prostate cancer was detected in 72 of the 141 patients (51%), including 44 of the 97 (45%) with PSA between 4.1 and 10 ng./ml. This incidence is higher than previously reported in the literature using other biopsy techniques. Disease was low grade Gleason 2 to 4 in 4 cases (5%), intermediate grade Gleason 5 to 6 in 26 (35%) and high grade Gleason 7 to 10 in the remaining 42 (60%).
CONCLUSIONS: A high cancer detection rate is achieved by 12-core transperineal prostate biopsy. Most tumors represent clinically significant cancer. Further randomized trials are required to confirm these data.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490231

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  Robotic prostate biopsy and its relevance to focal therapy of prostate cancer.

Authors:  Henry Ho; John S P Yuen; Christopher W S Cheng
Journal:  Nat Rev Urol       Date:  2011-09-20       Impact factor: 14.432

2.  [MRI navigated stereotactic prostate biopsy: fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies].

Authors:  T H Kuru; C Tulea; T Simpfendörfer; V Popeneciu; M Roethke; B A Hadaschik; M Hohenfellner
Journal:  Urologe A       Date:  2012-01       Impact factor: 0.639

Review 3.  The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis.

Authors:  Peng-Fei Shen; Yu-Chun Zhu; Wu-Ran Wei; Yong-Zhong Li; Jie Yang; Yu-Tao Li; Ding-Ming Li; Jia Wang; Hao Zeng
Journal:  Asian J Androl       Date:  2011-11-21       Impact factor: 3.285

4.  [-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.

Authors:  Brian V Le; Christopher R Griffin; Stacy Loeb; Gustavo F Carvalhal; Donghui Kan; Nikola A Baumann; William J Catalona
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

5.  Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer.

Authors:  Satoru Kawakami; Nobuhiko Hyochi; Junji Yonese; Masataka Yano; Yasuhisa Fujii; Yukio Kageyama; Iwao Fukui; Kazunori Kihara
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

6.  Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously.

Authors:  Clemens Brossner; Stefan Madersbacher; Phillip de Mare; Anton Ponholzer; Bader Al-Ali; Michael Rauchenwald
Journal:  World J Urol       Date:  2005-12-03       Impact factor: 4.226

7.  Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Authors:  Gabriela De Angelis; Harry G Rittenhouse; Stephen D Mikolajczyk; L Blair Shamel; Axel Semjonow
Journal:  Rev Urol       Date:  2007

8.  Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.

Authors:  Shady Nafie; Raj P Pal; John P Dormer; Masood A Khan
Journal:  World J Urol       Date:  2013-12-14       Impact factor: 4.226

Review 9.  Transperineal biopsy of the prostate--is this the future?

Authors:  Dwayne T S Chang; Benjamin Challacombe; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2013-09-24       Impact factor: 14.432

10.  Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma.

Authors:  Ziling Huang; Long Zhang; Xianghua Yi; Xiaoting Yu
Journal:  Tumour Biol       Date:  2015-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.